| Latest News and Updates |

Press Releases

Congratulations to Clarametyx Biosciences for raising $33 Million Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections

Newly established relationship with Cystic Fibrosis Foundation enables clinical studies targeting cystic fibrosis-associated infections...

Read Article

Congratulations to Clarametyx Biosciences for raising $33 Million Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections

Newly established relationship with Cystic Fibrosis Foundation enables clinical studies targeting cystic fibrosis-associated infections...

Read Article

Portfolio Update

Sep 3, 2024

Congratulations to Remedium on Securing an Oversubscribed Seed Extension Round

Congratulations to Remedium on Securing an Oversubscribed Seed Extension Round

Our New Opportunity: Sienza Energy, a Caltech-Incubated Battery Company Addresses Battery Safety for the EV Market

Our New Opportunity: Sienza Energy, a Caltech-Incubated Battery Company Addresses Battery Safety for the EV Market

Pinetree Therapeutics Closes $17 Million in Series A Funding to Advance AbReptor™ Protein Degradation Platform and Portfolio Programs

Pinetree Therapeutics Closes $17 Million in Series A Funding to Advance AbReptor™ Protein Degradation Platform and Portfolio Programs

Pinetree Therapeutics Announces Exclusive Option and Global License Agreement for Preclinical EGFR Degrader Candidate with AstraZeneca

Pinetree Therapeutics Announces Exclusive Option and Global License Agreement for Preclinical EGFR Degrader Candidate with AstraZeneca

CH4 Global and CirPro Australia Announce Successful Processing of First Cattle To Be Fed Methane Tamer™ at Commercial Scale

CH4 Global and CirPro Australia Announce Successful Processing of First Cattle To Be Fed Methane Tamer™ at Commercial Scale

Herantis Pharma receives research funding from The Michael J. Fox Foundation, US and the Parkinson's Virtual Biotech, UK

Herantis Pharma receives research funding from The Michael J. Fox Foundation, US and the Parkinson's Virtual Biotech, UK

Remedium Bio announces the publication of Prometheus™ dose-adjustable gene therapy platform data in the journal Gene

Remedium Bio announces the publication of Prometheus™ dose-adjustable gene therapy platform data in the journal Gene

Antion Biosciences announces development of safety-enhanced and off-the-shelf CAR T-cells for autoimmune disease

Antion Biosciences announces development of safety-enhanced and off-the-shelf CAR T-cells for autoimmune disease

Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH

Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH

Congratulations to Remedium Bio for Receiving Investment from Wharton Alumni Angels

Congratulations to Remedium Bio for Receiving Investment from Wharton Alumni Angels

Congratulations to Remedium Bio for Receiving Investment from SeedFolio to Advance Lead Asset

Congratulations to Remedium Bio for Receiving Investment from SeedFolio to Advance Lead Asset

Antion Biosciences announces latest data and validation of its technology platform through important milestone achievements

Antion Biosciences announces latest data and validation of its technology platform through important milestone achievements

CH4 Global Welcomes FDA Move on Animal Feed Additives

CH4 Global Welcomes FDA Move on Animal Feed Additives

Remedium Bio's Evidence of RMD1101 Disease Modificaton Published in Current Gene Therapy

Remedium Bio's Evidence of RMD1101 Disease Modificaton Published in Current Gene Therapy

CH4 Global Makes First Commercial Delivery of Its Methane-Reducing Cattle Feed Supplement

CH4 Global Makes First Commercial Delivery of Its Methane-Reducing Cattle Feed Supplement

Remedium Bio announces the appointment of James Carroll as the Chief Business Officer

Remedium Bio announces the appointment of James Carroll as the Chief Business Officer

Oxford Nanopore and Day Zero Diagnostics Partner to Develop a New Class of Bloodstream Infection Diagnostics

Oxford Nanopore and Day Zero Diagnostics Partner to Develop a New Class of Bloodstream Infection Diagnostics

Remedium Bio invited to showcase pipeline at the 2023 Life Sciences Summit

Remedium Bio invited to showcase pipeline at the 2023 Life Sciences Summit

Day Zero Diagnostics to Present AI-Based Antimicrobial Susceptibility Testing Predictive Models at IDWeek

Day Zero Diagnostics to Present AI-Based Antimicrobial Susceptibility Testing Predictive Models at IDWeek

Catalyzing Change with Climate Technology: CH4 Global and Lotte partner to Redefine Cattle Environmental Impact

Catalyzing Change with Climate Technology: CH4 Global and Lotte partner to Redefine Cattle Environmental Impact

Day Zero Diagnostics Announces Completion of $16M Financing Round

Day Zero Diagnostics Announces Completion of $16M Financing Round

Antion Biosciences Announces Granting of Key Technology Patent in the United States

Antion Biosciences Announces Granting of Key Technology Patent in the United States

CH4 Global Named on the 2023 Global Cleantech 100 Exceptional Innovators with the Determination and Technologies to Race to Net-Zero

CH4 Global Named on the 2023 Global Cleantech 100 Exceptional Innovators with the Determination and Technologies to Race to Net-Zero

Bantam Pharmaceutical to present at Biotech Showcase 2023

Bantam Pharmaceutical to present at Biotech Showcase 2023

Designing Immunotherapies that can overcome recurrence and resistance

Designing Immunotherapies that can overcome recurrence and resistance

PineTree Therapeutics Receives a Bits and Bytes Grant from Massachusetts Life Sciences Center

PineTree Therapeutics Receives a Bits and Bytes Grant from Massachusetts Life Sciences Center

BioEclipse Therapeutics Appoints New Board Member and Names Interim CFO

BioEclipse Therapeutics Appoints New Board Member and Names Interim CFO

Allogene and Antion collaborate on Multiplex miCAR Tech

Allogene and Antion collaborate on Multiplex miCAR Tech

Remedium Bio, Inc. announces research agreement to evaluate platform technology in Diabetes with the University of Massachusetts Boston

Remedium Bio, Inc. announces research agreement to evaluate platform technology in Diabetes with the University of Massachusetts Boston

Data on Bantam Pharmaceutical's Lead Drug

Data on Bantam Pharmaceutical's Lead Drug

CIRM awards $3.9M to Regencor for development of wearable injector

CIRM awards $3.9M to Regencor for development of wearable injector

CIRM awards $3.9M to Regencor for development of wearable injector treatment for cardiac regeneration

CIRM awards $3.9M to Regencor for development of wearable injector treatment for cardiac regeneration

Nodes Invited to Attend the 2021 Biofit Conference Programme

Nodes Invited to Attend the 2021 Biofit Conference Programme

Scioto Biosciences, Inc. Announces First Patient Dosed in Phase Ib Study in Patients Diagnosed with Autistic Disorder

Scioto Biosciences, Inc. Announces First Patient Dosed in Phase Ib Study in Patients Diagnosed with Autistic Disorder

Nodes Advisors Will Be in Attendance at Lsi2021 Emerging Medtech Summit

Nodes Advisors Will Be in Attendance at Lsi2021 Emerging Medtech Summit

Regencor wins, for the second year in a row, The Global Health & Pharma Biotechnology Awards 2021 as a "Leading Innovator in Cardiac Muscle Regeneration".

Regencor wins, for the second year in a row, The Global Health & Pharma Biotechnology Awards 2021 as a "Leading Innovator in Cardiac Muscle Regeneration".

Day Zero Diagnostics wins 2021 AACC award

Day Zero Diagnostics wins 2021 AACC award

Nodes Advisors selected to speak at the Festival Biologics 2020 Conference in Basel

Nodes Advisors selected to speak at the Festival Biologics 2020 Conference in Basel

Scioto Biosciences and Abigail Wexner Research Institute at Nationwide Children’s Hospital Receive a $2.3 Million Dollar Phase II SBIR Grant to Develop Novel Therapy

Scioto Biosciences and Abigail Wexner Research Institute at Nationwide Children’s Hospital Receive a $2.3 Million Dollar Phase II SBIR Grant to Develop Novel Therapy

Regencor awarded AMGEN Golden Ticket 2019

Regencor awarded AMGEN Golden Ticket 2019

Learning New Tricks from Pathogenic Bacteria to Target the Microbiome

Learning New Tricks from Pathogenic Bacteria to Target the Microbiome

Read

read

Get in touch

Contact us for more information about how we can help you invest in healthcare, biotech, climate tech, or advanced systems.

Press Releases

Congratulations to Clarametyx Biosciences for raising $33 Million Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections

Congratulations to Clarametyx Biosciences for raising $33 Million Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections

Congratulations to Remedium on Securing an Oversubscribed Seed Extension Round

Congratulations to Remedium on Securing an Oversubscribed Seed Extension Round

Our New Opportunity: Sienza Energy, a Caltech-Incubated Battery Company Addresses Battery Safety for the EV Market

Our New Opportunity: Sienza Energy, a Caltech-Incubated Battery Company Addresses Battery Safety for the EV Market

Pinetree Therapeutics Closes $17 Million in Series A Funding to Advance AbReptor™ Protein Degradation Platform and Portfolio Programs

Pinetree Therapeutics Closes $17 Million in Series A Funding to Advance AbReptor™ Protein Degradation Platform and Portfolio Programs

Pinetree Therapeutics Announces Exclusive Option and Global License Agreement for Preclinical EGFR Degrader Candidate with AstraZeneca

Pinetree Therapeutics Announces Exclusive Option and Global License Agreement for Preclinical EGFR Degrader Candidate with AstraZeneca

CH4 Global and CirPro Australia Announce Successful Processing of First Cattle To Be Fed Methane Tamer™ at Commercial Scale

CH4 Global and CirPro Australia Announce Successful Processing of First Cattle To Be Fed Methane Tamer™ at Commercial Scale

Herantis Pharma receives research funding from The Michael J. Fox Foundation, US and the Parkinson's Virtual Biotech, UK

Herantis Pharma receives research funding from The Michael J. Fox Foundation, US and the Parkinson's Virtual Biotech, UK

Remedium Bio announces the publication of Prometheus™ dose-adjustable gene therapy platform data in the journal Gene

Remedium Bio announces the publication of Prometheus™ dose-adjustable gene therapy platform data in the journal Gene

Antion Biosciences announces development of safety-enhanced and off-the-shelf CAR T-cells for autoimmune disease

Antion Biosciences announces development of safety-enhanced and off-the-shelf CAR T-cells for autoimmune disease

Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH

Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH

Congratulations to Remedium Bio for Receiving Investment from Wharton Alumni Angels

Congratulations to Remedium Bio for Receiving Investment from Wharton Alumni Angels

Congratulations to Remedium Bio for Receiving Investment from SeedFolio to Advance Lead Asset

Congratulations to Remedium Bio for Receiving Investment from SeedFolio to Advance Lead Asset

Antion Biosciences announces latest data and validation of its technology platform through important milestone achievements

Antion Biosciences announces latest data and validation of its technology platform through important milestone achievements

CH4 Global Welcomes FDA Move on Animal Feed Additives

CH4 Global Welcomes FDA Move on Animal Feed Additives

Remedium Bio's Evidence of RMD1101 Disease Modificaton Published in Current Gene Therapy

Remedium Bio's Evidence of RMD1101 Disease Modificaton Published in Current Gene Therapy

CH4 Global Makes First Commercial Delivery of Its Methane-Reducing Cattle Feed Supplement

CH4 Global Makes First Commercial Delivery of Its Methane-Reducing Cattle Feed Supplement

Remedium Bio announces the appointment of James Carroll as the Chief Business Officer

Remedium Bio announces the appointment of James Carroll as the Chief Business Officer

Antion Biosciences Interview with X-Health.show

Antion Biosciences Interview with X-Health.show

Antion Biosciences Present at the 7th CAR-TCR Summit in London (28-29 Feb 2024)

Antion Biosciences Present at the 7th CAR-TCR Summit in London (28-29 Feb 2024)

Oxford Nanopore and Day Zero Diagnostics Partner to Develop a New Class of Bloodstream Infection Diagnostics

Oxford Nanopore and Day Zero Diagnostics Partner to Develop a New Class of Bloodstream Infection Diagnostics

Remedium Bio invited to showcase pipeline at the 2023 Life Sciences Summit

Remedium Bio invited to showcase pipeline at the 2023 Life Sciences Summit

Day Zero Diagnostics to Present AI-Based Antimicrobial Susceptibility Testing Predictive Models at IDWeek

Day Zero Diagnostics to Present AI-Based Antimicrobial Susceptibility Testing Predictive Models at IDWeek

Catalyzing Change with Climate Technology: CH4 Global and Lotte partner to Redefine Cattle Environmental Impact

Catalyzing Change with Climate Technology: CH4 Global and Lotte partner to Redefine Cattle Environmental Impact

Day Zero Diagnostics Announces Completion of $16M Financing Round

Day Zero Diagnostics Announces Completion of $16M Financing Round

Antion Biosciences Announces Granting of Key Technology Patent in the United States

Antion Biosciences Announces Granting of Key Technology Patent in the United States

CH4 Global Named on the 2023 Global Cleantech 100 Exceptional Innovators with the Determination and Technologies to Race to Net-Zero

CH4 Global Named on the 2023 Global Cleantech 100 Exceptional Innovators with the Determination and Technologies to Race to Net-Zero

Bantam Pharmaceutical to present at Biotech Showcase 2023

Bantam Pharmaceutical to present at Biotech Showcase 2023

Designing Immunotherapies that can overcome recurrence and resistance

Designing Immunotherapies that can overcome recurrence and resistance

PineTree Therapeutics Receives a Bits and Bytes Grant from Massachusetts Life Sciences Center

PineTree Therapeutics Receives a Bits and Bytes Grant from Massachusetts Life Sciences Center

BioEclipse Therapeutics Appoints New Board Member and Names Interim CFO

BioEclipse Therapeutics Appoints New Board Member and Names Interim CFO

Allogene and Antion collaborate on Multiplex miCAR Tech

Allogene and Antion collaborate on Multiplex miCAR Tech

Remedium Bio, Inc. announces research agreement to evaluate platform technology in Diabetes with the University of Massachusetts Boston

Remedium Bio, Inc. announces research agreement to evaluate platform technology in Diabetes with the University of Massachusetts Boston

Data on Bantam Pharmaceutical's Lead Drug

Data on Bantam Pharmaceutical's Lead Drug

CIRM awards $3.9M to Regencor for development of wearable injector

CIRM awards $3.9M to Regencor for development of wearable injector

CIRM awards $3.9M to Regencor for development of wearable injector treatment for cardiac regeneration

CIRM awards $3.9M to Regencor for development of wearable injector treatment for cardiac regeneration

Nodes Invited to Attend the 2021 Biofit Conference Programme

Nodes Invited to Attend the 2021 Biofit Conference Programme

Scioto Biosciences, Inc. Announces First Patient Dosed in Phase Ib Study in Patients Diagnosed with Autistic Disorder

Scioto Biosciences, Inc. Announces First Patient Dosed in Phase Ib Study in Patients Diagnosed with Autistic Disorder

Nodes Advisors Will Be in Attendance at Lsi2021 Emerging Medtech Summit

Nodes Advisors Will Be in Attendance at Lsi2021 Emerging Medtech Summit

Regencor wins, for the second year in a row, The Global Health & Pharma Biotechnology Awards 2021 as a "Leading Innovator in Cardiac Muscle Regeneration".

Regencor wins, for the second year in a row, The Global Health & Pharma Biotechnology Awards 2021 as a "Leading Innovator in Cardiac Muscle Regeneration".

Day Zero Diagnostics wins 2021 AACC award